| Date | Time | Source | Headline | Symbol | Company |
| 07/11/2024 | 12:21PM | iHub Newswire | FeaturedCannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing | | |
| 04/24/2012 | 4:30AM | Zacks | Zacks Bull & Bear of the Day Highlights: UnitedHealth Group, Citi Trends, AstraZeneca plc, Ardea Biosciences & Takeda Pharmac.. | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 8:58PM | Business Wire | Robbins Umeda LLP Announces an Investigation of Ardea Biosciences, Inc. | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 8:54PM | Business Wire | Faruqi & Faruqi, LLP Announces Investigation of Ardea Biosciences, Inc. | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 5:28PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 5:24PM | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 4:35PM | PR Newswire (US) | Harwood Feffer LLP Announces Investigation of Ardea Biosciences, Inc. | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 3:43PM | Business Wire | The Law Firm of Weiss & Lurie Investigates Ardea Biosciences, Inc. | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 3:09PM | Business Wire | Pomerantz Law Firm Investigates Claims on Behalf of Investors of Ardea Biosciences, Inc. | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 12:43PM | Business Wire | Law Firm Brower Piven Announces Investigation in Connection With the Acquisition of Ardea Biosciences, Inc. by AstraZeneca Bi... | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 12:35PM | Business Wire | Ardea Biosciences, Inc. Board of Directors under Investigation for Potential Breaches of Fiduciary Duty by Glancy Binkow & Go... | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 11:31AM | Business Wire | The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Ardea ... | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 11:30AM | Business Wire | Ardea Biosciences Merger Investigated by the Securities Attorneys at The Briscoe Law Firm and Powers Taylor, LLP | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 11:02AM | PR Newswire (US) | Block & Leviton LLP Investigates Ardea Biosciences, Inc.'s Board of Directors for Possible Breaches of Fiduciary Duty | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 10:27AM | PR Newswire (US) | Ardea Biosciences, Inc. (RDEA) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition by AstraZenec... | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 8:00AM | Zacks | AstraZeneca to Buy Ardea Biosciences - Analyst Blog | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 2:46AM | Dow Jones News | AstraZeneca Buys Ardea Biosciences For $1.26 Billion/$32 A Share | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/23/2012 | 2:00AM | Marketwired | AstraZeneca to Acquire Ardea Biosciences for $1.26 Billion Including Lead Product Lesinurad in Phase III Development for Gout | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/10/2012 | 6:09AM | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/06/2012 | 7:37PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 04/04/2012 | 12:23PM | Zacks | Still Neutral on Ardea Biosciences - Analyst Blog | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 03/29/2012 | 7:34PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 03/12/2012 | 5:15AM | Zacks | Ardea Posts Lower Revs, Wider Loss - Analyst Blog | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 03/09/2012 | 5:11PM | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 03/09/2012 | 8:56AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 03/09/2012 | 8:30AM | Marketwired | Ardea Biosciences Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2011 Financial Results | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 03/07/2012 | 8:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 02/29/2012 | 7:41PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 02/29/2012 | 9:00AM | Marketwired | Ardea Biosciences to Present at Upcoming Investor Conferences | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |
| 02/10/2012 | 4:40PM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:RDEA | Ardea Biosciences, Inc. (MM) |